Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment

Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disorder with a low survival rate. Pulmonary fibrosis is one of the complications of COVID-19 and has a high prevalence in COVID-19 patients. Currently, no effective therapies other than lung transplantation are available to cure IPF and post-COV...

Full description

Bibliographic Details
Main Authors: Lingyue Yan, Yafei Su, Isaac Hsia, Ying Xu, Vui King Vincent-Chong, Wilfrido Mojica, Mukund Seshadri, Ruogang Zhao, Yun Wu
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
MT: Oligonucleotides: Therapies and Applications
miR-21
liposomes
pulmonary fibrosis
COVID-19
microRNA
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253123000513

Internet

http://www.sciencedirect.com/science/article/pii/S2162253123000513

Similar Items